Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 356.50M | 376.30M | 359.10M | 336.60M | 253.80M | 73.20M |
Gross Profit | 125.10M | 149.30M | 138.30M | 142.20M | 99.00M | 13.70M |
EBITDA | 52.70M | 74.70M | 55.00M | 49.60M | 48.60M | -22.20M |
Net Income | 10.50M | 27.20M | 9.10M | 7.90M | 7.10M | -48.20M |
Balance Sheet | ||||||
Total Assets | 720.00M | 701.90M | 722.60M | 732.60M | 749.70M | 746.80M |
Cash, Cash Equivalents and Short-Term Investments | 10.20M | 13.80M | 12.20M | 14.10M | 15.60M | 17.10M |
Total Debt | 208.40M | 215.20M | 209.60M | 218.70M | 228.20M | 325.10M |
Total Liabilities | 277.20M | 290.20M | 291.30M | 290.00M | 300.50M | 367.30M |
Stockholders Equity | 442.80M | 411.70M | 431.30M | 442.60M | 449.20M | 379.50M |
Cash Flow | ||||||
Free Cash Flow | 29.20M | 4.50M | 41.10M | 16.80M | 45.40M | -35.80M |
Operating Cash Flow | 54.00M | 57.70M | 68.30M | 47.50M | 71.20M | -19.30M |
Investing Cash Flow | -15.40M | -12.70M | -27.20M | -14.70M | -15.80M | -5.40M |
Financing Cash Flow | -48.80M | -43.40M | -43.00M | -34.30M | -56.90M | 21.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £1.69B | 10.10 | 6.90% | ― | 1.95% | 275.56% | |
74 Outperform | £273.62M | 6.19 | 10.69% | ― | 0.50% | ― | |
72 Outperform | £8.11M | 5.56 | 10.60% | 127.91% | 2.76% | ― | |
67 Neutral | £512.79M | 59.06 | 1.27% | 247.96% | 24.95% | -153.58% | |
67 Neutral | £856.87M | 15.24 | 16.38% | 186.33% | 3.70% | 57.10% | |
65 Neutral | £10.65B | 8.41 | 3.35% | 298.68% | -1.40% | 17.93% | |
56 Neutral | £322.14M | ― | 372.09% | ― | ― |